Long-term Follow-up of HLH Patients Who Received Treatment With NI-0501, an Anti-interferon Gamma Monoclonal Antibody
Status:
Completed
Trial end date:
2021-05-18
Target enrollment:
Participant gender:
Summary
International, multicenter, long-term, follow-up study that will enroll HLH patients who have
received NI-0501 in a previous clinical trial, in the context of the clinical development
program for NI-0501
Phase:
N/A
Details
Lead Sponsor:
NovImmune SA Swedish Orphan Biovitrum
Collaborators:
Seventh Framework Programme Supported by a grant of the 7th framework programme "FP7" from the European Committee